Givaudan SA (GVDNY)
| Market Cap | 44.52B +14.9% |
| Revenue (ttm) | 9.17B -1.8% |
| Net Income | 1.18B -12.8% |
| EPS | 2.49 -13.0% |
| Shares Out | n/a |
| PE Ratio | 38.59 |
| Forward PE | 29.61 |
| Dividend | 1.12 (1.16%) |
| Ex-Dividend Date | Mar 24, 2026 |
| Volume | 9,641 |
| Open | 96.74 |
| Previous Close | 95.09 |
| Day's Range | 96.23 - 97.05 |
| 52-Week Range | 65.97 - 97.40 |
| Beta | 0.62 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Jan 27, 2027 |
About Givaudan
Givaudan SA engages in the manufacture, supply, and sale of fragrance, beauty, taste, and wellbeing products to the consumer goods industry. It operates in two divisions, Fragrance & Beauty, and Taste & Wellbeing. The Fragrance & Beauty division offers fine fragrances; consumer products, such as personal, home, fabric, and oral care; fragrance ingredients; and active beauty products. The Taste & Wellbeing division provides beverages, such as fizzy drinks, bottled waters, ready-to-drink juices, and alcoholic drinks; dairy and cheese products, in... [Read more]
Financial Performance
In 2025, Givaudan's revenue was 7.47 billion, an increase of 0.81% compared to the previous year's 7.41 billion. Earnings were 1.07 billion, a decrease of -1.74%.
Financial numbers in CHF Financial StatementsNews
Givaudan price target raised to CHF 4,100 from CHF 3,700 at JPMorgan
JPMorgan analyst Celine Pannuti raised the firm’s price target on Givaudan (GVDNY) to CHF 4,100 from CHF 3,700 and keeps an Overweight rating on the shares.
Givaudan Shares Climb After Sales Beat Expectations
Shares were up more than 6% after the supplier of food ingredients and perfume scents's sales rose 11% compared with the year-earlier period.
Givaudan Q3 Sales Rise; Confirms LFL Sales Growth View For Mid-long Term
(RTTNews) - Givaudan AG (GVDBF.PK), a Swiss manufacturer of flavors, fragrances, and cosmetic ingredients, reported Tuesday higher sales in its third quarter on a reported and like-for-like basis. Fur...
Givaudan Earnings release: Q3 2026
Givaudan released its Q3 2026 earnings on October 13, 2026, summarizing the period's financial results.
Givaudan's quarterly organic sales beat market view on fragrance strength
Givaudan's quarterly organic sales beat market view on fragrance strength
Givaudan upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Alex Sloane upgraded Givaudan (GVDNY) to Overweight from Equal Weight with a price target of CHF 3,850, up from CHF 3,450. The firm sees an attractive risk/reward following…
Givaudan price target raised to CHF 3,450 from CHF 3,150 at Citi
Citi raised the firm’s price target on Givaudan (GVDNY) to CHF 3,450 from CHF 3,150 and keeps a Neutral rating on the shares.
Givaudan price target raised to CHF 3,700 from CHF 3,600 at JPMorgan
JPMorgan analyst Celine Pannuti raised the firm’s price target on Givaudan (GVDNY) to CHF 3,700 from CHF 3,600 and keeps an Overweight rating on the shares.
Givaudan price target raised to CHF 3,700 from CHF 3,650 at Deutsche Bank
Deutsche Bank raised the firm’s price target on Givaudan (GVDNY) to CHF 3,700 from CHF 3,650 and keeps a Buy rating on the shares.
Givaudan downgraded to Hold from Buy at Jefferies
Jefferies analyst Marcus Dunford-Castro downgraded Givaudan (GVDNY) to Hold from Buy with a price target of CHF 3,030, down from CHF 3,700. The firm says Fine Fragrance’s premiumization advantage is…
Givaudan downgraded to Underweight from Equal Weight at Morgan Stanley
Morgan Stanley analyst Lisa De Neve downgraded Givaudan (GVDNY) to Underweight from Equal Weight with a price target of CHF 2,900, down from CHF 2,950. The company has below-peer growth…
Givaudan Slides: Investor presentation
Givaudan has posted slides in relation to its latest quarterly earnings report, which was published on August 27, 2026.
India investigates fragrance giants over price collusion, document shows
Global fragrance makers Givaudan , Firmenich and International Flavors & Fragrances face a second antitrust investigation by Indian authorities, according to a regulatory document seen by Reuters.
Givaudan price target raised to CHF 3,650 from CHF 3,300 at Deutsche Bank
Deutsche Bank analyst Virginie Boucher-Ferte raised the firm’s price target on Givaudan (GVDNY) to CHF 3,650 from CHF 3,300 and keeps a Buy rating on the shares. Published first on…
Givaudan Earnings Call Transcript: Q2 2026
Solid H1 2026 results with 3.6% like-for-like sales growth and strong Fragrance & Beauty momentum, despite non-recurring costs and currency headwinds. Sequential improvement in Taste & Wellbeing and robust project pipeline support confidence in meeting 2030 targets.
Givaudan Earnings release: Q2 2026
Givaudan released its Q2 2026 earnings on July 23, 2026, summarizing the period's financial results.
Givaudan Slides: Q2 2026
Givaudan has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on July 23, 2026.
Givaudan Quarterly report: Q2 2026
Givaudan has published its Q2 2026 quarterly earnings report on July 23, 2026.
Givaudan initiated with an Underperform at Bernstein
Bernstein initiated coverage of Givaudan (GVDNY) with an Underperform rating and CHF 2,886 price target The firm says that after 15 years of market outperformance versus chemicals, sector rotation and...
Givaudan price target raised to CHF 3,300 from CHF 3,100 at Barclays
Barclays analyst Alex Sloane raised the firm’s price target on Givaudan (GVDNY) to CHF 3,300 from CHF 3,100 and keeps an Equal Weight rating on the shares. The company’s second…
Givaudan price target raised to CHF 2,900 from CHF 2,875 at Morgan Stanley
Morgan Stanley analyst Lisa De Neve raised the firm’s price target on Givaudan (GVDNY) to CHF 2,900 from CHF 2,875 and keeps an Equal Weight rating on the shares. Published…
Givaudan upgraded to Buy from Hold at Deutsche Bank
Deutsche Bank analyst Virginie Boucher-Ferte upgraded Givaudan (GVDNY) to Buy from Hold with a price target of CHF 3,300, up from CHF 3,000. The firm says the company is seeing…
Givaudan Slides: Investor presentation
Givaudan has posted slides in relation to its latest quarterly earnings report, which was published on June 9, 2026.
Givaudan upgraded to Buy from Sell at Goldman Sachs
Goldman Sachs upgraded Givaudan (GVDNY) to Buy from Sell with a price target of CHF 3,500, up from CHF 2,900. The firm made seven rating changes in European chemicals, “positioning…
Givaudan downgraded to Hold from Buy at Kepler Cheuvreux
Kepler Cheuvreux downgraded Givaudan (GVDNY) to Hold from Buy with a price target of CHF 3,000, down from CHF 3,600. The firm cites the stock’s premium multiple for the downgrade.